Biotec Services Doubles Temperature-Controlled Processing Capacity - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Biotec Services Doubles Temperature-Controlled Processing Capacity


Biotec Services International, a UK-based global provider of temperature-controlled packaging and distribution services for clinical trials, is doubling its capacity with the addition of new processing facilities. The company is increasing its controlled room-temperature storage by 100% and its cold-room storage by 400%. It is also creating a second advanced therapeutic medicinal products facility.

"Feedback from our recent client survey indicated that refrigerated storage at +2°C to +8°C is the range that most suits our partners' requirements, so we are developing our facilities in line with this and also bespoke temperature demands," said Dr. Fiona Withey, CEO of Biotec Services, in a press release. As part of the company's strategic growth plans, it has also acquired land adjacent to the current Biotec Services' facilities, which will be developed in line with client demands. 

Source: Biotec Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here